Why Neos Therapeutics Shares Are Hitting a New Low
Neos Therapeutics saw its shares sink after the company announced that it had priced its secondary offering of common stock.
All Work
Chris Lange
What Is Driving Fortinet’s Earnings?
Shares of Fortinet soared in the wake of better-than-expected fourth-quarter financial results.
How Chipotle Took a Big Bite Out of Earnings
Shares of Chipotle Mexican Grill retreated early Friday after it reported mixed fourth-quarter financial results late Thursday.
Why GoPro Earnings Fell Short
GoPro reported mixed fourth-quarter financial results late on Thursday, and shares fell sharply Friday morning.
Why Amgen Earnings Are So Incredible
Amgen Inc. (NASDAQ: AMGN) reported its fourth-quarter financial results after the markets closed on Thursday. This biotech giant posted $2.89 in earnings per share (EPS) and $5.97 billion in revenue, versus consensus estimates that…
Why Visa Won Big on Q1 Earnings
Visa Inc. (NYSE; V) released its fiscal first-quarter earnings report after the markets closed on Thursday. The company said that it had $0.86 in earnings per share (EPS) on $4.5 billion in revenue. The…
Why the Ralph Lauren CEO Departure Might Be a Blessing in Disguise
Ralph Lauren shares hit a new multiyear low on Thursday after the company reported its most recent earnings and the departure of its CEO. Ralph Lauren's stock has not been at this price level…
Why Benitec More Than Doubled
Benitec Biopharma saw its shares more than double on Tuesday after the company gave a business update on its ddRNAi technology for the development of therapeutics for the treatment of ocular diseases.
Why Analysts Keep Getting More Bullish on Facebook
After Facebook reported its most recent financial results late Wednesday, shares were up handily in the after-hours trading session, but the gains have flattened out on Thursday.
Why Amag Pharmaceuticals Is Sinking Despite Positive Top-Line Results
AMAG Pharmaceuticals shares took a sharp turn down after the company reported top-line results from its most recent pharmacokinetic study.
Can Shutterfly Turn Itself Around After This Earnings Miss?
Shutterfly released a disappointing fourth-quarter earnings report after the markets closed on Wednesday, and shares tanked early Thursday.
Why Merck’s Q4 Earnings Aren’t Enough for Investors
Merck reported disappointing fourth-quarter financial results before the markets opened on Thursday.
Why Facebook Is Reaching Record Highs After Earnings
Facebook, Inc. (NASDAQ: FB) reported its fourth-quarter financial results after the markets closed on Wednesday. The social media giant posted $1.41 in earnings per share (EPS) and $8.81 billion in revenue, compared with consensus…
Top 6 Earnings To Watch For On Thursday
Although this earnings season has been relatively positive, the Dow has stepped away from its 20,000 mark, and it seems the animal spirits powering this rally might not be as positive as they once…
Why Credit Suisse Is Growing More Negative on Movie Theaters
Credit Suisse cut its ratings for a few of the largest movie theaters chains, after forecasting weaker domestic attendance growth despite a strong movie slate for 2017.
The Top 2 Dow Stocks Reporting on Thursday
24/7 Wall St. has put together a preview of the two Dow stocks scheduled to report their quarterly results on Thursday: Merck and Visa.
Massive Analyst Capitulation in Under Armour
Under Armour saw its shares get crushed on Tuesday after the company reported earnings. Unfortunately this wasn’t the end of it.
How High Analysts Are Chasing Apple’s Price Targets
Earnings propped up Apple's stock for Wednesday’s rally, but as more analysts continue to weigh in the stock it could run even more.
Why Investors Cheered Anthem Earnings
Anthem released a better-than-expected earnings report before the markets opened on Wednesday, pushing shares to a new high.
Investors Can’t Make Up Their Minds on Altria Earnings
Altria reported better-than-expected fourth-quarter financial results before the markets opened on Wednesday.